FrancophonIA/ELRC3.0 huggingface dataset:
English: Multipack: 12 (12 packs of 1) pre-filled syringes (0.4 ml) with pre-assembled needle with needle guard and alcohol swabs
Croatian: Višestruko pakiranje: 12 (12 pakiranja po 1) napunjenih štrcaljki (0,4 ml) sa spojenom iglom sa štitnikom za iglu i alkoholnim tupferima.
English: Multipack: 6 (6 packs of 1) pre-filled syringes (0.8 ml) with pre-assembled needle with needle guard and alcohol swabs
Croatian: Višestruko pakiranje: 6 (6 pakiranja po 1) napunjenih štrcaljki (0,8 ml) sa spojenom iglom sa štitnikom za iglu i alkoholnim tupferima.
English: 1 pre-filled syringe (0.6 ml) with pre-assembled needle with needle guard and 2 alcohol swabs.
Croatian: 1 napunjena štrcaljka (0,6 ml) sa spojenom iglom sa štitnikom za iglu i 2 alkoholna tupfera.
English: 1 pre-filled syringe (0.3 ml) with pre-assembled needle with needle guard and 2 alcohol swabs Multipack: 4 (4 packs of 1) pre-filled syringes (0.3 ml) with pre-assembled needle with needle guard and alcohol swabs
Croatian: 1 napunjena štrcaljka (0,3 ml) sa spojenom iglom sa štitnikom za iglu i 2 alkoholna tupfera Višestruko pakiranje: 4 (4 pakiranja po 1) napunjene štrcaljke (0,3 ml) sa spojenom iglom sa štitnikom za iglu i alkoholnim tupferima.
English: Multipack: 12 (12 packs of 1) pre-filled syringes (0.6 ml) with pre-assembled needle with needle guard and alcohol swabs
Croatian: Višestruko pakiranje: 12 (12 pakiranja po 1) napunjenih štrcaljki (0,6 ml) sa spojenom iglom sa štitnikom za iglu i alkoholnim tupferima.
English: 1 pre-filled syringe (0.6 ml) with pre-assembled needle with needle guard and 2 alcohol swabs Multipack: 4 (4 packs of 1) pre-filled syringes (0.6 ml) with pre-assembled needle with needle guard and alcohol swabs
Croatian: 1 napunjena štrcaljka (0,6 ml) sa spojenom iglom sa štitnikom za iglu i 2 alkoholna tupfera Višestruko pakiranje: 4 (4 pakiranja po 1) napunjene štrcaljke (0,6 ml) sa spojenom iglom sa štitnikom za iglu i alkoholnim tupferima.
English: Multipack: 12 (12 packs of 1) pre-filled syringes (0.3 ml) with pre-assembled needle with needle guard and alcohol swabs
Croatian: Višestruko pakiranje: 12 (12 pakiranja po 1) napunjenih štrcaljki (0,3 ml) sa spojenom iglom sa štitnikom za iglu i alkoholnim tupferima.
English: Multipack: 12 (12 packs of 1) pre-filled syringes (0.8 ml) with pre-assembled needle with needle guard and alcohol swabs
Croatian: Višestruko pakiranje: 12 (12 pakiranja po 1) napunjenih štrcaljki (0,8 ml) sa spojenom iglom sa štitnikom za iglu i alkoholnim tupferima.
English: Multipack: 6 (6 packs of 1) pre-filled syringes (0.3 ml) with pre-assembled needle with needle guard and alcohol swabs
Croatian: Višestruko pakiranje: 6 (6 pakiranja po 1) napunjenih štrcaljki (0,3 ml) sa spojenom iglom sa štitnikom za iglu i alkoholnim tupferima.
English: Nordimet 20 mg solution for injection in pre-filled pen methotrexate
Croatian: Nordimet 20 mg otopina za injekciju u napunjenoj brizgalici metotreksat
English: 1 pre-filled syringe (0.3 ml) with pre-assembled needle with needle guard and 2 alcohol swabs.
Croatian: 1 napunjena štrcaljka (0,3 ml) sa spojenom iglom sa štitnikom za iglu i 2 alkoholna tupfera.
English: 1 pre-filled syringe (0.4 ml) with pre-assembled needle with needle guard and 2 alcohol swabs Multipack: 4 (4 packs of 1) pre-filled syringes (0.4 ml) with pre-assembled needle with needle guard and alcohol swabs
Croatian: 1 napunjena štrcaljka (0,4 ml) sa spojenom iglom sa štitnikom za iglu i 2 alkoholna tupfera Višestruko pakiranje: 4 (4 pakiranja po 1) napunjene štrcaljke (0,4 ml) sa spojenom iglom sa štitnikom za iglu i alkoholnim tupferima.
English: Multipack: 6 (6 packs of 1) pre-filled syringes (0.6 ml) with pre-assembled needle with needle guard and alcohol swabs
Croatian: Višestruko pakiranje: 6 (6 pakiranja po 1) napunjenih štrcaljki (0,6 ml) sa spojenom iglom sa štitnikom za iglu i alkoholnim tupferima.
English: Nordimet 7.5 mg solution for injection in pre-filled syringe Nordimet 10 mg solution for injection in pre-filled syringe Nordimet 12.5 mg solution for injection in pre-filled syringe Nordimet 15 mg solution for injection in pre-filled syringe Nordimet 17.5 mg solution for injection in pre-filled syringe Nordimet 20 mg solution for injection in pre-filled syringe Nordimet 22.5 mg solution for injection in pre-filled syringe Nordimet 25 mg solution for injection in pre-filled syringe methotrexate
Croatian: Nordimet 7,5 mg otopina za injekciju u napunjenoj štrcaljki Nordimet 10 mg otopina za injekciju u napunjenoj štrcaljki Nordimet 12,5 mg otopina za injekciju u napunjenoj štrcaljki Nordimet 15 mg otopina za injekciju u napunjenoj štrcaljki Nordimet 17,5 mg otopina za injekciju u napunjenoj štrcaljki Nordimet 20 mg otopina za injekciju u napunjenoj štrcaljki Nordimet 22,5 mg otopina za injekciju u napunjenoj štrcaljki Nordimet 25 mg otopina za injekciju u napunjenoj štrcaljki metotreksat
English: 1 pre-filled syringe (0.8 ml) with pre-assembled needle and needle guard and 2 alcohol swabs.
Croatian: 1 napunjena štrcaljka (0,8 ml) sa spojenom iglom sa štitnikom za iglu i 2 alkoholna tupfera.
English: EU/1/16/1124/013 - 4 pack (4 packs of 1) EU/1/16/1124/014 - 6 pack
Croatian: EU/1/16/1124/013 - 4 pakiranja (4 pakiranja po 1) EU/1/16/1124/014 - 6 pakiranja EU/1/16/1124/061 - 4 pakiranja (1 pakiranje po 4) EU/1/16/1124/062 - 12 pakiranja
English: Nordimet 7.5 mg solution for injection in pre-filled syringe Nordimet 10 mg solution for injection in pre-filled syringe Nordimet 12.5 mg solution for injection in pre-filled syringe Nordimet 15 mg solution for injection in pre-filled syringe Nordimet 17.5 mg solution for injection in pre-filled syringe Nordimet 20 mg solution for injection in pre-filled syringe Nordimet 22.5 mg solution for injection in pre-filled syringe Nordimet 25 mg solution for injection in pre-filled syringe
Croatian: Nordimet 7,5 mg otopina za injekciju u napunjenoj štrcaljki Nordimet 10 mg otopina za injekciju u napunjenoj štrcaljki Nordimet 12,5 mg otopina za injekciju u napunjenoj štrcaljki Nordimet 15 mg otopina za injekciju u napunjenoj štrcaljki Nordimet 17,5 mg otopina za injekciju u napunjenoj štrcaljki Nordimet 20 mg otopina za injekciju u napunjenoj štrcaljki Nordimet 22,5 mg otopina za injekciju u napunjenoj štrcaljki Nordimet 25 mg otopina za injekciju u napunjenoj štrcaljki
English: Nordimet 7.5 mg solution for injection in pre-filled pen methotrexate
Croatian: Nordimet 7,5 mg otopina za injekciju u napunjenoj brizgalici metotreksat
English: Nordimet 10 mg solution for injection in pre-filled pen methotrexate
Croatian: Nordimet 10 mg otopina za injekciju u napunjenoj brizgalici metotreksat
English: Subcutaneous use.
Croatian: Supkutano.
English: The European Commission issued a decision on 27 February 2017.
Croatian: Europska komisija objavila je odluku 27. veljače 2017.
English: It is normally used as the sulfate salt.
Croatian: Obično se upotrebljava kao sulfatna sol.
English: What is gentamicin?
Croatian: Što je gentamicin?
English: 30 Churchill Place ● Canary Wharf ● London E14 5EU ● United Kingdom27 February 2017
Croatian: 30 Churchill Place ● Canary Wharf ● London E14 5EU ● United Kingdom27. veljače 2017.
English: Outcome of a referral procedure under Article 35 of Directive 2001/82/EC (EMEA/V/A/117)
Croatian: Ishod postupka upućivanja u skladu s člankom 35. Direktive 2001/82/EZ (EMEA/V/A/117)
English: Which data has the CVMP reviewed?
Croatian: Koje je podatke ocijenio CVMP?
English: Gentamicin is an aminoglycoside antibiotic indicated for the treatment of a variety of bacterial infections.
Croatian: Gentamicin je aminoglikozidni antibiotik indiciran za liječenje raznih bakterijskih infekcija.
English: The CVMP was requested to review all available residue depletion data and recommend withdrawal periods for cattle (meat and milk) and pigs (meat and offal).
Croatian: Od CVMP-a je zatraženo da pregleda sve dostupne podatke o izlučivanju rezidua i preporuči razdoblja karencije za goveda (meso i mlijeko) i svinje (meso i iznutrice).
English: Questions and answers on veterinary medicinal products containing gentamicin presented as solutions for injection to be administered to cattle and pigs EMA/144816/2017
Croatian: Pitanja i odgovori o veterinarsko-medicinskim proizvodima koji sadržavaju gentamicin u obliku otopina za injekciju za primjenu u goveda i svinja EMA/144816/2017
English: Belgium noted that there are different approved withdrawal periods for cattle and pigs for veterinary medicinal products containing gentamicin presented as solutions for injection across the European Union, e.g. cattle meat and offal from 28 days to 210 days; cattle milk from 2 to 7 days, with some of the products stating ‘do not use in cows whose milk is intended for human consumption'; and pig meat and offal from 28 days to 150 days.
Croatian: Belgija je primijetila da su diljem Europske unije odobrena različita razdoblja karencije za goveda i svinje za veterinarsko-medicinske proizvode koji sadržavaju gentamicin u obliku otopina za injekciju, npr. za meso i iznutrice goveda od 28 do 210 dana, za mlijeko goveda od 2 do 7 dana, s napomenom „nije za primjenu u krava čije je mlijeko namijenjeno prehrani ljudi” u nekih od proizvoda, te za meso i iznutrice svinja od 28 do 150 dana.
English: On 8 January 2016, Belgium initiated a procedure under Article 35 of Directive 2001/82/EC for veterinary medicinal products containing gentamicin presented as solutions for injection to be administered to cattle and pigs, due to concerns related to the withdrawal periods set for the aforementioned products.
Croatian: Belgija je 8. siječnja 2016. pokrenula postupak u skladu s člankom 35. Direktive 2001/82/EZ za veterinarsko-medicinske proizvode koji sadržavaju gentamicin u obliku otopina za injekciju za primjenu u goveda i svinja zbog zabrinutosti u pogledu razdoblja karencije utvrđenih za navedene proizvode.
English: On 10 November 2016, the European Medicines Agency (the Agency) completed a review of the consumer safety of the withdrawal periods for cattle (meat and milk) and pigs (meat and offal) for veterinary medicinal products containing gentamicin presented as solutions for injection.
Croatian: Europska agencija za lijekove (Agencija) dovršila je 10. studenoga 2016. ocjenjivanje sigurnosti potrošača u pogledu razdoblja karencije za goveda (meso i mlijeko) i svinje (meso i iznutrice) za veterinarsko-medicinske proizvode koji sadržavaju gentamicin u obliku otopina za injekciju.
English: Why were veterinary medicinal products containing gentamicin presented as solutions for injection reviewed?
Croatian: Zašto su veterinarsko-medicinski proizvodi koji sadržavaju gentamicin u obliku otopina za injekciju ponovno ocijenjeni?
English: Questions and answers on veterinary medicinal products containing gentamicin presented as solutions for injection to be administered to cattle and pigs
Croatian: Pitanja i odgovori o veterinarsko-medicinskim proizvodima koji sadržavaju gentamicin u obliku otopina za injekciju za primjenu u goveda i svinja
English: The CVMP recommended that the marketing authorisations for veterinary medicinal products containing gentamicin presented as solutions for injection should be varied in order to amend the product information accordingly.
Croatian: CVMP je preporučio izmjenu odobrenja za stavljanje u promet veterinarskomedicinskih proizvoda koji sadržavaju gentamicin u obliku otopina za injekciju kako bi se informacije o proizvodu na odgovarajući način izmijenile.
English: Based on the evaluation of the currently available data, the CVMP concluded that the overall benefitrisk balance for veterinary medicinal products containing gentamicin presented as solutions for injection is positive and agreed that the withdrawal periods for cattle (meat and milk) and pigs (meat and offal) should be amended to provide assurance for consumer safety and also agreed that the subcutaneous route should no longer be recommended for cattle and pigs since the depletion kinetics from the injection site remain unknown.
Croatian: CVMP je na temelju evaluacije trenutačno dostupnih podataka zaključio da je ukupni omjer koristi i rizika za veterinarsko-medicinske proizvode koji sadržavaju gentamicin u obliku otopina za injekciju pozitivan te se složio da je potrebno izmijeniti razdoblja karencije za goveda (meso i mlijeko) i svinje (meso i iznutrice) kako bi se zajamčila sigurnost potrošača, a također se složio da supkutana primjena više ne bi trebala biti u preporukama za goveda i svinje jer je kinetika izlučivanja s mjesta injiciranja i dalje nepoznata.
English: The Agency's Committee for Medicinal Products for Veterinary Use (CVMP) concluded that the overall benefit-risk balance for veterinary medicinal products containing gentamicin presented as solutions for injection is positive and recommended amendments to withdrawal periods for cattle and pigs to provide assurance for consumer safety.
Croatian: Odbor za veterinarsko-medicinske proizvode (CVMP) pri Agenciji zaključio je da je ukupni omjer koristi i rizika za veterinarsko-medicinske proizvode koji sadržavaju gentamicin u obliku otopina za injekciju pozitivan te je preporučio izmjenu razdoblja karencije za goveda i svinje kako bi se zajamčila sigurnost potrošača.
English: Proprietary data and scientific references on residue depletion were provided by the marketing authorisation holders.
Croatian: Nositelji odobrenja za stavljanje VMP-a u promet pružili su podatke proizvođača i znanstvene referentne izvore o izlučivanju rezidua.
English: Dzuveo should not be used for more than 48 hours.
Croatian: Dzuveo se ne smije upotrebljavati dulje od 48 sati.
English: Further information on Dzuveo can be found on the Agency's website: ema.europa.eu/Find medicine/Human medicines/European public assessment reports.
Croatian: Više informacija o lijeku Dzuveo možete naći na internetskim stranicama Agencije: ema.europa.eu/Find medicine/Human medicines/European public assessment reports.
English: The most common side effects (which may affect more than 1 in 10 people) are nausea, vomiting and fever.
Croatian: Najčešće nuspojave (koje se mogu javiti u više od 1 na 10 osoba) jesu mučnina, povraćanje i groznica.
English: Patients should not eat or drink and should talk as little as possible for the 10 minutes after taking the tablet.
Croatian: Bolesnici ne smiju jesti ni piti te trebaju što manje govoriti tijekom 10 minuta nakon uzimanja tablete.
English: Attaching to these receptors in the brain helps relieve the patient's pain.
Croatian: Vezanje na te receptore u mozgu pomaže olakšati bolesnikov bol.
English: This means that it is similar to a ‘reference medicine' (called Sufenta Forte) containing the same active substance.
Croatian: To znači da je sličan „referentnom lijeku” (naziva Sufenta Forte) koji sadrži istu djelatnu tvar.
English: What measures are being taken to ensure the safe and effective use of Dzuveo?
Croatian: Koje se mjere poduzimaju kako bi se osigurala sigurna i učinkovita primjena lijeka Dzuveo?
English: What is Dzuveo and what is it used for?
Croatian: Što je Dzuveo i za što se koristi?
English: It is a ‘hybrid medicine'.
Croatian: Dzuveo je „hibridni lijek”.
English: Using a disposable applicator, the healthcare professional should place one tablet under the patient's tongue and leave it to dissolve.
Croatian: Zdravstveni radnik treba s pomoću jednokratnog aplikatora staviti jednu tabletu pod jezik bolesnika i ostaviti je da se otopi.
English: The most serious side effects with sufentanil are severe breathing problems, which occur in around 6 people in 1,000.
Croatian: Najozbiljnije nuspojave pri primjeni sufentanila jesu teški problemi s disanjem, koji se javljaju u oko 6 osoba na 1000.
English: It should be given by a healthcare professional experienced in treating pain and in a place (such as a hospital) where the patient can be monitored.
Croatian: Trebaju ga davati samo zdravstveni radnici s iskustvom u liječenju bola i u okruženjima u kojima se bolesnika može nadzirati (kao što je bolnica).
English: Other information about Dzuveo
Croatian: Ostale informacije o lijeku Dzuveo
English: For more information about using Dzuveo, see the package leaflet or contact your doctor or pharmacist.
Croatian: Za više informacija o primjeni lijeka Dzuveo pogledajte uputu o lijeku ili se obratite liječniku ili ljekarniku.
English: Dzuveo is available as 30 µg sublingual tablets.
Croatian: Dzuveo je dostupan u obliku sublingvalnih tableta od 30 µg.
English: Dzuveo must not be used in patients with serious lung or breathing problems.
Croatian: Dzuveo se ne smije primjenjivati u bolesnika koji imaju teške probleme s plućima ili disanjem.
English: Recommendations and precautions to be followed by healthcare professionals and patients for the safe and effective use of Dzuveo have been included in the summary of product characteristics and the package leaflet.
Croatian: Preporuke i mjere opreza kojih se zdravstveni radnici i bolesnici trebaju pridržavati u cilju sigurne i učinkovite primjene lijeka Dzuveo nalaze se u sažetku opisa svojstava lijeka i u uputi o lijeku.
English: What are the risks associated with Dzuveo?
Croatian: Koji su rizici povezani s lijekom Dzuveo?
English: The tablet must not be chewed or swallowed.
Croatian: Tablete lijeka Dzuveo ne smiju se žvakati ni gutati.
English: Why is Dzuveo authorised in the EU?
Croatian: Zašto je lijek Dzuveo odobren u EU-u?
English: As for all medicines, data on the use of Dzuveo are continuously monitored.
Croatian: Kao za sve lijekove, podatci o primjeni lijeka Dzuveo kontinuirano se prate.
English: An overview of Dzuveo and why it is authorised in the EU
Croatian: Pregled informacija o lijeku Dzuveo i zašto je odobren u EU-u
English: Side effects reported with Dzuveo are carefully evaluated and any necessary action taken to protect patients.
Croatian: Nuspojave prijavljene za lijek Dzuveo pažljivo se procjenjuju i poduzimaju se potrebne mjere za zaštitu bolesnika.
English: They can be given the tablets as needed but should wait at least one hour after one tablet before having another.
Croatian: Tablete se mogu davati po potrebi, no između uzimanja tableta treba proći najmanje sat vremena.
English: Dzuveo contains the active substance sufentanil.
Croatian: Dzuveo sadrži djelatnu tvar sufentanil.
English: The European Medicines Agency therefore decided that Dzuveo's benefits are greater than its risks and it can be authorised for use in the EU.
Croatian: Europska agencija za lijekove zaključila je da koristi od lijeka Dzuveo nadmašuju s njim povezane rizike te da lijek može biti odobren za primjenu u Europskoj uniji.
English: Dzuveo can only be obtained with a prescription.
Croatian: Dzuveo se izdaje samo na recept.
English: The difference between the products is that Dzuveo is available as sublingual tablets (tablets to be dissolved under the tongue) while the reference medicine is a solution for injection.
Croatian: Proizvodi se razlikuju u tome što je Dzuveo dostupan u obliku sublingvalnih tableta (tablete koje se tope pod jezikom), dok je referentni lijek otopina za injekciju.
English: Dzuveo is an opioid pain medicine used to treat moderate to severe pain in adults.
Croatian: Dzuveo je opioidni lijek protiv bolova koji se primjenjuje za liječenje umjerenog do snažnog bola u odraslih.
English: In the second study in 101 patients after foot surgery, pain reduced by around 6 points with Dzuveo and increased by around 7 points with placebo.
Croatian: U drugom ispitivanju provedenom na 101 bolesniku nakon operacije stopala bol se uz primjenu lijeka Dzuveo smanjio za oko 6 bodova, a uz primjenu placeba porastao je za oko 7 bodova.
English: In the first study in 163 patients who had undergone abdominal surgery, pain reduced by 26 points with Dzuveo compared with 13 points with placebo (a dummy treatment).
Croatian: U prvom ispitivanju provedenom na 163 bolesnika koji su bili podvrgnuti operaciji abdomena bol se uz primjenu lijeka Dzuveo smanjio za 26 bodova, a uz primjenu placeba (prividnog liječenja) za 13 bodova.
English: Both studies used a pain rating scale known as SPID12 which tracks reduction in pain over 12 hours.
Croatian: U obama ispitivanjima upotrijebljena je ljestvica za utvrđivanje razine bola poznata pod nazivom SPID12, s pomoću koje se tijekom 12 sati prati smanjenje bola.
English: The active substance in Dzuveo, sufentanil, is an opioid that works by attaching to receptors (targets) in the brain known as μ-opioid receptors.
Croatian: Djelatna tvar lijeka Dzuveo, sufentanil, opioid je koji djeluje vezanjem na receptore u mozgu (mete) poznate pod nazivom μ-opioidni receptori.
English: Two main studies have shown that Dzuveo left to dissolve under the tongue is effective at reducing severe pain following surgeries.
Croatian: U dvama glavnim ispitivanjima dokazano je da Dzuveo ostavljen da se otopi ispod jezika djelotvorno smanjuje snažan bol nakon operacija.
English: What benefits of Dzuveo have been shown in studies?
Croatian: Koje su koristi lijeka Dzuveo dokazane u ispitivanjima?
English: How does Dzuveo work?
Croatian: Kako djeluje Dzuveo?
English: How is Dzuveo used?
Croatian: Kako se Dzuveo koristi?
English: Studies show that Dzuveo is effective at reducing severe pain following surgeries.
Croatian: Ispitivanja su pokazala da Dzuveo djelotvorno smanjuje snažan bol nakon operacija.
English: The side effects seen with Dzuveo are those expected with opioids, and are considered manageable.
Croatian: Nuspojave koje se javljaju pri primjeni lijeka Dzuveo očekivane su pri primjeni opioida i smatra se da se mogu držati pod kontrolom.
English: For the full list of side effects and restrictions with Dzuveo, see the package leaflet.
Croatian: Potpuni popis nuspojava i ograničenja pri primjeni lijeka Dzuveo potražite u uputi o lijeku.
English: The recommended dose is 60 mg once a day.
Croatian: Preporučena je doza 60 mg jedanput na dan.
English: Patients should not eat for at least two hours before and one hour after taking Cabometyx.
Croatian: Bolesnici ne smiju jesti najmanje dva sata prije i jedan sat nakon uzimanja lijeka Cabometyx.
English: Further information on Cabometyx can be found on the Agency's website: ema.europa.eu/en/medicines/human/EPAR/cabometyx.
Croatian: Više informacija o lijeku Cabometyx nalazi se na internetskim stranicama Agencije: ema.europa.eu/en/medicines/human/EPAR/cabometyx.
English: The improvement in survival observed is considered significant considering that these patients have poor outcomes and few treatment options available.
Croatian: Primijećeno poboljšanje u pogledu preživljenja smatra se značajnim s obzirom na činjenicu da ti pacijenti imaju slabe ishode i malo dostupnih mogućnosti liječenja.
English: These patients have poor outcomes and a high unmet medical need.
Croatian: Ti bolesnici imaju slabe ishode i visoku nezadovoljenu medicinsku potrebu.
English: Cabometyx is available as tablets (20, 40 and 60 mg).
Croatian: Lijek Cabometyx dostupan je u obliku tableta (od 20, 40 i 60 mg).
English: Cabometyx received a marketing authorisation valid throughout the EU on 9 September 2016.
Croatian: Lijek Cabometyx dobio je odobrenje za stavljanje u promet koje je na snazi u EU-u od 9. rujna 2016.
English: What measures are being taken to ensure the safe and effective use of Cabometyx?
Croatian: Koje se mjere poduzimaju kako bi se osigurala sigurna i učinkovita primjena lijeka Cabometyx?
English: By blocking the activity of these enzymes in cancer cells, the medicine reduces the growth and spread of the cancer.
Croatian: Onemogućivanjem djelovanja tih enzima u stanicama raka lijek smanjuje rast i širenje raka.
English: These enzymes can be found in certain receptors in cancer cells, where they are involved in activating processes that include cell division and the growth of new blood vessels to supply the cancer.
Croatian: Ti se enzimi nalaze u određenim receptorima u stanicama raka, gdje sudjeluju u aktivaciji procesa koji uključuju diobu stanica i stvaranje novih krvnih žila za opskrbu raka.
English: Cabometyx (cabozantinib)
Croatian: Cabometyx (kabozantinib)
English: Other information about Cabometyx
Croatian: Ostale informacije o lijeku Cabometyx